


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.08%
+3.35%
+0.55%
+2.37%
-3.63%
RVMD
Revolution Medicines Inc.
$118.75
Strengths

Upgraded on attractively valued

Outperform the market
RVMD Price Performance
$78.51 (+51.25%)
$47.5 (+150.00%)
$36.52 (+225.16%)
$40.73 (+191.55%)
RVMD has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

RVMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market
![]()
RVMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RVMD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is RVMD current stock price?
What are RVMD stock strengths?
What is RVMD Risk Level?
What is RVMD market cap and volume?
What is RVMD current Stock IQ?
Should I buy RVMD stock right now?
Is RVMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for RVMD?
What does a 'Strong Sell' rating mean for RVMD?
What factors influence RVMD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.08%
+3.35%
+0.55%
+2.37%
-3.63%
RVMD
Revolution Medicines Inc.
Current Price
$118.75
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market

RVMD Price Performance
$78.51 (+51.25%)
$47.5 (+150.00%)
$36.52 (+225.16%)
$40.73 (+191.55%)
RVMD Analysts Opinion
RVMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market
![]()
RVMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RVMD Street Sentiment is extremely bullish and have positive views on the near-term outlook
RVMD has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
RVMD Stock IQ
RVMD Latest Analysis
Revolution Medicines: Strong Buy As Acquisition Prospects Continue To Circle.
Fri Jan 9, 2026
Revolution Medicines: Pivotal Trial Readouts Coming And Buyout Rumors Churning.
Fri Jan 9, 2026
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight. ) is reportedly in talks to acquire cancer drug-maker RVMD) in a deal potentially valued at between $28 and $32 billion.Shares of Revolution Medicines were up 4.56% on Thursday before soaring 15.14% overnight after the news broke out now trading at $123.65 per share. The deal is yet to be finalized and any potential tie-ups are weeks away according to a report by the Financial Times
Fri Jan 9, 2026
RVMD Crosses Above Average Analyst Target. In recent trading shares of Revolution Medicines Inc (Symbol: RVMD) have crossed above the average analyst 12-month target price of $84.11 changing hands for $102.71/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgra
Thu Jan 8, 2026
Why Revolution Medicines Shares Are Sliding After Hours On Wednesday. Shares of RVMD) tumbled in after-hours trading on Wednesday after ) denied reports that it was in talks to acquire the cancer-drug developer reversing an over 28% rally sparked by the takeover speculation.The Wall Street Journal on Wednesday that AbbVie was in advanced talks to buy Revolution Medicines but the terms and a potential purchase price were not disclosed. Revolution Medicines had also attracted interest from other
Thu Jan 8, 2026
Revolution Medicines (RVMD) Hits All-Time High on Buyout Buzz. Buyer Denies Talks. We recently published 10 Stocks With Massive Gains. 5 at Record Highs. Revolution Medicines Inc. (NASDAQ:RVMD) was one of the top performers on Wednesday. Revolution Medicines soared to a new all-time high on Wednesday as investors took path from a report from The Wall Street Journal that it was set to be acquired by AbbVie [….]
Thu Jan 8, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RVMD Stock trends
RVMD Stock performance
RVMD Stock analysis
RVMD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.